Join us for a fundraising event with a thought-provoking discussion featuring biotech executives and founders on advancing novel clinical strategies and targets for cancer, followed by cocktails and networking – all hosted at beautiful One Canal in Cambridge, MA! Ticket proceeds support our client company Larkspur Biosciences' CEO Catherine Sabatos-Peyton upcoming climb of Mount Kilimanjaro with Luke Timmerman’s Timmerman Traverse benefiting Damon Runyon Cancer Research Foundation! When: Thursday, November 13, 2025 | 5 - 7:30 p.m. Get Tickets: https://lnkd.in/gzYSnSwU
Breakthrough Properties
Real Estate
Los Angeles, California 8,567 followers
A Tishman Speyer & Bellco Capital Joint Venture.
About us
Breakthrough Properties is a life science real estate investment firm that leverages cross-sector collaboration to deliver environments that foster innovation and scientific breakthroughs. Our team is a first-of-its-kind collaboration in real estate development, which came together through a shared passion that combines Tishman Speyer’s global real estate platform with Bellco Capital’s industry-making biotechnology entrepreneurship to capitalize on the rapidly expanding — yet substantially under-supplied — life science real estate industry. Our teams develop and operate world-class mission critical facilities for the most innovative companies. A destination for life changing discoveries. We have combined Tishman-Speyer’s decades of global real estate development experience with Bellco Capital’s industry-making biotechnology entrepreneurship to reimagine environments where companies can create life-changing therapies for patients. At Breakthrough, we seek to be a home for scientific discovery and innovation because we understand what you do, how you do it and why you do it.
- Website
-
http://www.btprop.com
External link for Breakthrough Properties
- Industry
- Real Estate
- Company size
- 51-200 employees
- Headquarters
- Los Angeles, California
- Type
- Partnership
- Founded
- 2019
- Specialties
- Real Estate Development, Life Sciences, and BioTech
Locations
Employees at Breakthrough Properties
Updates
-
We are proud to welcome Pfizer to Torrey Heights and to continue supporting their innovation in life-changing cancer therapies!
Incredible visit to our La Jolla site. This team has delivered real breakthroughs that are changing how we treat patients around the world. The site is entering a new chapter, and the energy I felt today was unmistakable. The spirit of discovery that will drive our next breakthrough in cancer research is alive and well. Thank you to the colleagues who welcomed me and continue to lead with purpose. #PfizerProud
-
-
Governor Pointe is actively leasing StudioLabs, Science-Ready Suites, and fully customizable shell space to perfectly suit your needs in our newest life science campus. With premium amenities including a state-of-the-art fitness center, a serviced café, and convenient access to I-805 and CA-52, this is where innovation meets convenience. Connect with Greg Bowman to learn more and secure your space today! Thank you to Sūdenim Visual Media for capturing the drone footage!
-
We were happy to host the Philly BioBreak community for a fantastic event at 2300 Market by Breakthrough! Thanks to everyone who joined us – it’s a pleasure to welcome the community into this stunning lobby!
Thank you to the #Philly BioBreak community for another fantastic evening of connection and collaboration! It’s inspiring to see this network continue to grow and bring together life sciences leaders across the region. A special thank you to our sponsors: Locust Walk, Breakthrough Properties, Duane Morris LLP, The Higgins Group, Inc., and Troutman Pepper Locke LLP, for making the night possible, and to the beautiful new 2300 Market Street for hosting us. We’re excited to keep building momentum with this community and look forward to many more conversations and opportunities ahead. #Biotech #Networking #LifeSciences #PhillyBioBreak #IndustryLeaders
-
-
Exciting developments from our client company Larkspur Biosciences whose CEO Catherine Sabatos-Peyton announced they are aiming to enter clinical trials by end of year with their innovative cancer treatment program. Larkspur was one of the first companies to move into One Canal, our asset in East Cambridge, Boston. We're proud to be supporting their business and team in these innovative new modalities and appreciate the shoutout on Biotech TV!
𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐂𝐄𝐎 𝐒𝐢𝐬𝐭𝐞𝐫𝐡𝐨𝐨𝐝 𝐚𝐭 𝐍𝐘𝐒𝐄: Catherine Sabatos-Peyton is leading Larkspur Biosciences, a company targeting cancer cell fitness. She describes the work the company is doing, which has a lead program targeting PIP4K2C and is scheduled to be in the clinic later this year. Full video: https://lnkd.in/e4Akw4Vu BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Klein Hersh | Savills | Genezen